Question 5: Magnesium Sulphate for Acute Asthma in children

Area of Science:

• Pediatric Emergency Medicine
• Respiratory Medicine
• Pharmacology

Background:

• Standard acute asthma treatment in children includes inhaled beta-agonists, oxygen, and systemic steroids.
• Evidence for secondary treatment options in severe pediatric asthma attacks is less defined.
• Intravenous magnesium sulfate (MgSO4) is frequently used, with nebulized forms emerging in initial therapy.

Purpose of the Study:

• To examine the role of magnesium sulfate (MgSO4) in acute asthma management in children.
• To explore the potential mechanisms of action for MgSO4 in pediatric asthma.
• To review current recommendations and evidence supporting MgSO4 use.

Main Methods:

• Literature review of studies on magnesium sulfate in acute pediatric asthma.
• Analysis of evidence for both nebulized and intravenous administration of MgSO4.
• Synthesis of current clinical recommendations and research findings.

Main Results:

• Discusses the potential physiological effects of MgSO4 in bronchodilation and reducing airway inflammation.
• Presents evidence supporting the efficacy of both intravenous and nebulized MgSO4 in specific pediatric asthma cohorts.
• Highlights variability in current treatment guidelines and practice.

Conclusions:

• Magnesium sulfate represents a valuable option for severe acute asthma in children unresponsive to initial therapies.
• Further research is needed to clarify optimal dosing, administration routes, and long-term effects.
• Standardizing the use of MgSO4 in pediatric asthma protocols requires robust evidence.